HCPCS Code S0164: Injection, pantoprazole sodium, 40 mg

HCPCS code S0164 was the Level II code for injection, pantoprazole sodium, 40 mg, and it was deleted effective July 1, 2024. Its direct replacement is J2470, which carries the identical description and the identical 40 mg dose.

J2470 is active in the current code set, and Medicare Part B recognizes it. S0164 never had that status, because Medicare excludes the whole S-series from payment.

Two product-specific J-codes sit alongside J2470, and the right one depends on the vial or bag the practice dispensed. This reference sets out the ICD-10 pairings, the NDC rules, the denial patterns, and the buy-and-bill workflow that applies today.

Found our content helpful?

Key takeaways

HCPCS code S0164 described injection of pantoprazole sodium 40 mg, an S-series code issued for non-Medicare payers.

S0164 was deleted effective July 1, 2024, and it cannot be used for dates of service on or after that date.

J2470 is the direct replacement. It carries the same description, injection of pantoprazole sodium 40 mg, and Medicare recognizes it.

Match the J-code to the product you dispensed. J2471 covers the Hikma formulation and J2472 covers the Baxter premixed bag.

J3490 is the unclassified-drug code. It applies only where no drug-specific code exists, and pantoprazole now has three.

Practice management software like Pabau supports HCPCS code assignment, payer-rule enforcement, and claim scrubbing for injection billing.

What is HCPCS code S0164?

HCPCS code S0164 was the Level II code for injection, pantoprazole sodium, 40 mg, a parenteral proton pump inhibitor. CMS maintained it as part of the HCPCS Level II code set, which covers drugs, devices, and services that CPT does not describe.

The S-series was issued for non-Medicare payers such as Medicaid managed care plans and commercial insurers. The code is now deleted, but its historical record still matters for claim research, appeals, and audit response.

S0164 code details at a glance

About pantoprazole sodium (Protonix): Clinical background

Pantoprazole sodium is a proton pump inhibitor that irreversibly blocks the hydrogen-potassium ATPase enzyme system of the gastric parietal cell. Blocking that enzyme suppresses acid secretion.

The drug is marketed under the brand name Protonix. The intravenous formulation is used when a patient cannot tolerate oral dosing, typically in inpatient or observation settings.

According to FDA-approved labeling for pantoprazole sodium, the drug’s clinical indications include:

• Gastroesophageal reflux disease (GERD) with erosive esophagitis
• Zollinger-Ellison syndrome and other pathological hypersecretory conditions
• Short-term treatment where rapid acid suppression is needed and oral therapy is not feasible

The indications matter for billing because medical necessity documentation has to match the diagnosis codes on the claim. Payers running utilization review check that the billed ICD-10 diagnosis is consistent with the indication for parenteral PPI therapy.

Current status of S0164: Is this code still active?

S0164 is a deleted HCPCS code, removed in the quarterly update that took effect July 1, 2024. It cannot be used for dates of service on or after that date, and a claim carrying it is rejected on system logic.

CMS retires a code when a permanent code already covers the same drug, when usage falls away, or when a better pathway exists. S0164 was retired for the first reason, since J2470 already described the same drug at the same dose.

Billers who find S0164 on historical claims, remittances, or audit files should read it as valid for its own date of service. A 2023 remittance showing S0164 is not an error. For any current date of service, bill J2470 and confirm the payer’s drug policy first.

J2470 and the replacement codes for S0164

J2470 is the replacement code for S0164. Both carry the same long description, injection of pantoprazole sodium 40 mg, so the crosswalk is one to one. Two product-specific codes sit alongside it, and which one applies depends on the vial or bag dispensed.

Key crosswalk rule: bill J2470 unless the dispensed product matches J2471 or J2472. One unit equals 40 mg, so a single 40 mg vial bills as one unit. Include the 11-digit NDC from that vial, with its unit qualifier and quantity, on the claim line. The chart below folds the date of service into that choice.

When J3490 still applies

J3490 is the unclassified-drug code, and it applies only where no drug-specific HCPCS code exists for the product. Pantoprazole now has three, so J3490 is a rare exception rather than the crosswalk.

Use it only where a payer has no J2470 entry on its fee schedule and tells you in writing to bill unclassified. The claim line then needs the drug name, the strength, the NDC, and the units in the narrative field.

Two neighboring codes get confused with J3490. J3590 covers unclassified biologics and J9999 covers unlisted antineoplastic drugs. Neither one fits pantoprazole, and neither is a crosswalk for S0164.

Payer coverage for pantoprazole injection

Coverage now runs through J2470 for every payer type, Medicare included. The table below shows where S0164 stood while it was active and what applies today. Verify the current drug policy with each payer through their provider portal before you order the drug.

Why Medicare never covered HCPCS S-codes

S-codes are temporary codes reserved for non-Medicare payers. CMS created the series so Medicaid and commercial plans could bill drugs and services with no CPT or J-code of their own. Medicare runs a separate pathway, using J-codes for injectable drugs under Part B coverage.

An S-code sent to a Medicare Administrative Contractor is rejected by system logic, before any coverage decision is made. The exclusion is categorical. Reading the payer’s denial codes tells a team which rejection they are looking at, so the claim gets rerouted to J2470.

ICD-10 diagnosis codes that support medical necessity

Payers require a medically appropriate ICD-10 diagnosis code on every claim line to establish medical necessity for parenteral pantoprazole.

The codes below are the ones most often linked to pantoprazole administration, based on the drug’s FDA-approved indications. Coverage still varies by payer, so treat this table as a clinical reference rather than a guarantee of reimbursement.

Use the most specific code the documentation supports. Submitting a less-specific code where a more specific one applies is a common audit finding. Verify each code’s validity for the claim date of service with the CDC ICD-10-CM web tool.

NDC crosswalk: National drug codes for pantoprazole sodium 40 mg

The National Drug Code has to appear on the claim line alongside J2470. NDC numbers identify the product, its manufacturer, and the package size. That is how a payer confirms the drug you billed is the drug you gave.

Generic manufacturers reissue NDCs when they reformulate or repackage, so check current numbers against the FDA NDC Directory. The table below sets out the format and the fields payers check.

Buy-and-bill workflow for pantoprazole injection

Buy-and-bill is the model where the practice purchases the drug, administers it, and then bills the payer for both the drug and its administration.

These claims carry more detail than a simple service line, because the drug and the administration are priced separately. The steps below reflect current practice for pantoprazole sodium injection under J2470.

1. Verify payer coverage before ordering. Confirm the payer carries J2470 on its drug fee schedule and check whether prior authorization applies. Note any product requirement that would push the claim to J2471 or J2472.
2. Obtain and document prior authorization where required. Many commercial payers require prior auth for buy-and-bill drugs. The authorization number has to appear on the claim.
3. Purchase and document the drug with the vial label NDC. Record the NDC from the dispensed vial, the lot number, and the expiration date in the patient record. The NDC on the claim must match the dispensed product.
4. Administer and document the injection. Record the route of administration, the dose, and the clinician who gave it. That note is what supports medical necessity if the claim is audited.
5. Submit the claim with the drug code, NDC, diagnosis, and administration code. Pair J2470 with the correct IV push or infusion administration CPT code. Attach the ICD-10 code for the documented condition and the NDC from the vial.
6. Post the ERA and resolve denials promptly. Review the electronic remittance advice for adjustment reason codes. Missing NDCs, absent prior authorization, and unsupported diagnoses account for most rejections.

Documentation requirements and medical necessity

Commercial and Medicaid managed care payers run pre-payment or post-payment review on buy-and-bill drug claims. A clean submission for parenteral pantoprazole needs all of the following in the chart and on the claim:

• Confirmed ICD-10 diagnosis supporting parenteral PPI therapy
• Physician order specifying the drug, dose, route, and frequency
• Documentation that oral PPI therapy is not feasible, or was trialed and failed
• Nursing or clinician administration note with time, dose, and route
• NDC with unit qualifier and quantity billed on the claim line
• Prescriber NPI and facility or group NPI
• Prior authorization number where the plan requires one

A missing element on that list gives the payer grounds to deny the claim or claw the payment back. Checking each field at charge entry keeps the claim from going out incomplete.

Common denial reasons and how to prevent them

Most rejections on a pantoprazole line trace back to six causes, and five of them are preventable at the point of charge entry. The table below pairs each denial with the control that stops it.

How practice management software simplifies HCPCS billing

HCPCS billing for injectable drugs has several moving parts. Teams have to track retired codes, manage NDC crosswalks, enforce payer-specific rules, and close out documentation before submission. Manual handling introduces error at each of those steps.

Practice management software like Pabau supports HCPCS code assignment, payer-rule enforcement, and claim scrubbing. A missing NDC or a retired code then surfaces before submission rather than after a denial.

Pabau’s claims management software flags outdated codes when a quarterly HCPCS update is applied. Billing staff then review a short exception list instead of the whole code library.

For practices running buy-and-bill drugs alongside other services, a single platform connects the clinical note to the billing queue. Administration notes, NDC data, and diagnosis codes then reach the claim without manual re-entry, which removes a common source of transcription error. Billing managers also get live claim status in one place.

Simplify HCPCS billing from documentation to payment

Pabau connects clinical notes, HCPCS code assignment, NDC tracking, and claim submission in one platform. Your billing team catches errors before they turn into denials.

Book a demo

Conclusion

Set S0164 to retire in your code library and the rest of this falls into place. The date of service tells you whether the old code was legitimate, and the vial label tells you which J-code replaces it.

The trade-off worth remembering is that a deleted code rarely fails loudly. It rejects on system logic, weeks after the drug was given. A quarterly review of the code set catches the next S0164 before a claim does.

Buy-and-bill claims reward documentation discipline, from the physician order through to ERA reconciliation. Book a demo to see how Pabau keeps HCPCS code changes and NDC tracking off your billing team’s memory.

Continue your research

Need a framework for managing claim denials on drug injection codes? Denial management in healthcare covers the core workflow for categorizing, appealing, and preventing rejections.

Want to understand how HCPCS fits into the broader billing picture? What is revenue cycle management explains the end-to-end process from claim creation to payment posting.

Looking for guidance on payer credentialing to unlock commercial plan coverage? How to get credentialed with insurance companies walks through the enrollment steps for commercial and managed care plans.

Frequently asked questions

Billing and payer questions about S0164